Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Parker

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Blood|October 8, 2008
A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroupsSarina Sulong, Anthony V Moorman, Julie A E Irving, et al.
Brain : a Journal of Neurology|November 30, 2017
Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapyRebecca J Holley, Stuart M Ellison, Daniel Fil, et al.
Blood Advances|October 29, 2024
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypesStella Charalampopoulou, Elise Chapiro, Ferran Nadeu, et al.
Blood Advances|May 31, 2022
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLLGiorgia Chiodin, Samantha Drennan, Enrica A Martino, et al.
Plos One|November 7, 2015
Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor LocusChantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, et al.
Clinical and Translational Medicine|February 26, 2021
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemiaMiguel Quijada-Álamo, Claudia Pérez-Carretero, María Hernández-Sánchez, et al.
Haematologica|March 11, 2021
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patientsSilvia Ramos-Campoy, Anna Puiggros, Sílvia Beà, et al.
Blood Advances|July 29, 2021
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphomaJonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingMarina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Blood|October 8, 2008
A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroupsSarina Sulong, Anthony V Moorman, Julie A E Irving, et al.
Brain : a Journal of Neurology|November 30, 2017
Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapyRebecca J Holley, Stuart M Ellison, Daniel Fil, et al.
Blood Advances|October 29, 2024
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypesStella Charalampopoulou, Elise Chapiro, Ferran Nadeu, et al.
Blood Advances|May 31, 2022
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLLGiorgia Chiodin, Samantha Drennan, Enrica A Martino, et al.
Plos One|November 7, 2015
Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor LocusChantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, et al.
Clinical and Translational Medicine|February 26, 2021
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemiaMiguel Quijada-Álamo, Claudia Pérez-Carretero, María Hernández-Sánchez, et al.
Haematologica|March 11, 2021
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patientsSilvia Ramos-Campoy, Anna Puiggros, Sílvia Beà, et al.
Blood Advances|July 29, 2021
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphomaJonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingMarina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Pageof 9